<i>SORL1</i> mutation in a Greek family with Parkinson's disease and dementia
Georgia Xiromerisiou(German Center for Neurodegenerative Diseases), John Hardy(UK Dementia Research Institute), Monia Hammer(National Institutes of Health), Aleksey Ermolaev(Russian State Agrarian University - Moscow Timiryazev Agricultural Academy), Cleanthe Spanaki(University Hospital of Heraklion), Alaa Khan(National Hospital for Neurology and Neurosurgery), Thomas Bourinaris(University College London), Monica Federoff(School of the Art Institute of Chicago), Jana Vandrovcová(Texas Tech University), Liana Fidani(Aristotle University of Thessaloniki), Henry Houlden(Queen Mary University of London), Sevasti Bonstanjopoulou(Aristotle University of Thessaloniki), Ziv Gan‐Or(Montreal Neurological Institute and Hospital), Andrew Singleton(Short and Associates (United States)), Patrick A. Lewis(National Hospital for Neurology and Neurosurgery), Georgios M. Hadjigeorgiou, Konstantin Senkevich(Montreal Neurological Institute and Hospital)
Cited by 12
Related Papers
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
|Nature Genetics|2009|3.4k
Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk
|Nature Genetics|2019|2.5k
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
|Nature Genetics|2011|2.1k